“There’s never been a more exciting time to invest in life sciences – the rapid acceleration of technology is poised to revolutionize how we restore and optimize health.”
When he’s away from DSM Venturing, Arpesh can be found exploring everything the food scene in New York City has to offer.
Before joining DSM in 2019, Arpesh managed venture capital and growth equity investments for Black River, an institutional asset management company owned by Cargill. Arpesh started his career in various technical roles related to biotechnology development.
Arpesh holds a BA in Biology from the University of Pennsylvania, an MS in Biomedical Engineering from UCLA, and an MBA from Northwestern University.
